Sabby Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-93,295
Closed -$830K 115
2018
Q2
$830K Buy
93,295
+1,310
+1% +$11.7K 0.13% 32
2018
Q1
$812K Sell
91,985
-39,944
-30% -$353K 0.1% 36
2017
Q4
$1.35M Buy
+131,929
New +$1.35M 0.12% 16
2017
Q3
Sell
-52,982
Closed -$476K 164
2017
Q2
$476K Buy
+52,982
New +$476K 0.03% 62